Beam Therapeutics (NASDAQ:BEAM) said it plans to cut approximately 20% of its workforce, or around 100 jobs, as part of a corporate restructuring initiative. As a result of the layoffs, which are ...

Hundreds of construction workers at ground zero watched Tuesday night as the last steel beam left standing at the demolished World Trade Center was cut down, marking the end of the unprecedented ...

As you might know, Beam Therapeutics Inc. (NASDAQ:BEAM) just kicked off its latest annual results with some very strong numbers. The results were impressive, with revenues of US$378m exceeding analyst ...

Oct 19 (Reuters) - Beam Therapeutics (BEAM.O), opens new tab said on Thursday it will focus on developing its experimental sickle cell disease treatments and reduce about 20% of its current workforce, ...